CellEctric Biosciences
Private Company
Funding information not available
Overview
CellEctric Biosciences is a seed-stage, Vienna-based company pioneering 'electrome' technology for precise cell manipulation via electric fields. Its primary application is a diagnostic sample preparation platform that selectively removes human host cells to unmask viable pathogens, aiming to accelerate and improve detection in sepsis and other infections. The company is running pilot collaborations with diagnostic partners, has a protected IP portfolio, and is positioned at the intersection of cell therapy enabling tools and advanced diagnostics.
Technology Platform
Proprietary 'Electrome' platform using selective electromagnetic fields for cell manipulation. Core function is non-denaturing, selective lysis of human host cells in complex samples while leaving pathogens viable, for improved diagnostic sample preparation.
Opportunities
Risk Factors
Competitive Landscape
Competes in the diagnostic sample preparation market against established chemical and mechanical lysis methods. Its selective, non-denaturing approach using electric fields is a key differentiator. Long-term, in cell therapy tools, it would face competition from established electroporation companies and other cell engineering technologies.